Epidermal growth factor receptor (EGFR) has been shown to be overexpressed in many human cancers, including lung [15, 16], central nervous system [17], head and neck [18], bladder [19], pancreas [20], and breast [21]; and it correlates with poor prognosis [22]. This evidence concerns the gene EGFR and cancer.